Rojas VG, Ortega LJM, Ortega CJJ

Language: Spanish
References: 30
Page: 200-206
PDF size: 360.49 Kb.

ABSTRACT

Aortic stenosis is currently the most common valvular disease. Its incidence increases with the aging of the population. It is becoming more frequent to encounter this group of elderly patients who often present with another comorbid chronic condition. Not only is the management if these patients complex and multidisciplinary but it is also known that symptomatic aortic stenosis poses high five year mortality. However, there are still points which are worth of further discussion in regards of the current management options. Recently, new therapeutic options have emerged such as percutaneous valve replacement which still has unclear indications. This article presents a current discussion of the topic.

REFERENCES

1. Selser A. Changing aspects of the natural history of valvular aortic stenosis. New Engl J Med 1987; 317: 91-98.

2. Wood P. Aortic Stenosis. Am J Cardiol 1958; 1: 553-571.

3. Edwards JE. Calcific aortic stenosis: pathologic features. Proc Staff Mett Mayo Clin 1961; 36: 441-451.

4. Roberts WC. Anatomically isolated aortic valvular disease: the case againts its being of rheumatic etiology. Am J Med 1970; 49: 151-159.

5. Sverdlov A, Ngo D, Chapman M et al. Pathogenesis of aortic stenosis: not just a matter of wear and tear. Am J Cardiovasc Dis 2011; 1 (2): 185-199.

6. Lombard JT, Selzer A. Valvular Aortic Stenosis: clinical and hemodynamic profile of patients. Ann Intern Med 1987; 106: 292-298.

7. Otto CM, Burwash IG, Legget ME et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95: 2262-2270.

8. Rosenhek R, Binder T, Porenta G et al. Predictor of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611-617.

9. Martínez Ríos M, Vargas-Barrón J, Lorenzo JA et al. Tratado de Cardiología del Instituto Nacional de Cardiología; 2012: 566-573.

10. Bonow R, Carabello B, Chatterjee K et al. ACC/AHA 2006 Practice guidelines for the management of patients with valvular heart disease: executive summary. J Am Coll Cardiol 2006; 48: 598-675.

11. Pibarot P, Dumesnil J. Improving Assessment of Aortic Stenosis. J Am Coll Cardiol 2012; 60: 169-180.

12. Gallego, Pastora. Papel de la resonancia magnética en la evaluación de las valvulopatías. Rev Esp Cardiol 2011; 64 (Supl 2): 10-18.

13. Khot U, Novaro G, Popovic Z et al. Nitroprusside in critically Ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 2003; 348: 1756-1763.

14. Cowell J, Newby Q, Prescott R et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352: 2389-2397.

15. Rosseb A, Pedersen T, Bouman K et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359: 1343-1356.

16. O’Brien KD, Probstfield JL, Caulfield MT et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 2005; 165: 858-862.

17. Innasimuthu AL, Katz WE. Effect of bisphosphonates on the progression of degenerative aortic stenosis. Echocardiography 2011; 28: 1-7.

18. Aksony O, Cam A, Goel S et al. Do bisphosphonates slow the progression of aortic stenosis?. J Am Coll Cardiol 2012; 59: 1452-1459.

19. Stewart RA, Kerr AJ, Cowan BR et al. A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis. Am Heart J 2008; 156: 348-355.

20. Schwarz F, Baumann P, Manthey J et al. The effect of aortic valve replacement on survival. Circulation 1982; 66: 1105-1110.

21. Kelly TA, Rothbart RM, Cooper CM, Kaiser DL et al. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol 1988; 61: 123-130.

22. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically signifcant aortic stenosis. J Am Coll Cardiol 1990; 15: 1012-1017.

23. Tseng EE, Lee CA, Cameron DE et al. Aortic valve replacement in the elderly: risk factors and long-term results. Ann Surg 1997; 225: 793-802.

24. Otto CM, Mickel MC, Kennedy JW et al. Three-year outcome after balloon aortic valvuloplasty: insights into prognosis of valvular aortic stenosis. Circulation 1994; 89: 642-650.

25. Rahimtoola SH. Catheter balloon valvuloplasty for severe calcific aortic stenosis: a limited role. J Am Coll Cardiol 1994; 23: 1076-78.

26. Pereira JJ, Balaban K, Lauer MS, Lytle B, Thomas JD, Garcia MJ. Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery. Am J Med 2005; 118: 735-742.

27. Patel JH, Mathew ST, Hennebry TA. Transcatheter aortic valve replacement: a potential option for the nonsurgical patient. Clin Cardiol 2009; 32 (6): 296-301.

28. Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106 (24): 3006-3008.

29. Makkar RR, Fontana GP, Jilaihawi H et al. PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012; 366 (18): 1696-1704.

30. Kodali SK, Williams MR, Smith CR et al. PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366 (18): 1686-1695.